Insulin treatment prevented the upregulation in tubular damage markers Kim-1 and Ngal thus confirming that STZ does not exert tubular damage [29] at the doses used in this study and that the observed effects might be attributed to hyperglycemia. The gene discussed is HAVCR1; the disease is Hyperglycemia.